Offering Accelerated Delivery of Phase I Clinical Trial Materials

Utilizing Patheon’s network of specialized development centers throughout North America and Europe, the Quick to Clinic™ program allows for rapid provision of clinical trial materials for first time in human (phase I) studies.

• Fast, Flexible, Proven
- Delivery in 4 Months

• Specialized early phase development centers
- Global network
- No scheduling competition with late phase projects

• Simple, fit for purpose formulations
- Blend in capsule
- API in bottle
- API in capsule
- Tablets
- Blend in bottle
- Oral solutions

Contact us to learn more about how Patheon can help bring your new molecule to clinic faster using less API.

QTM Salesheet.pdf

QTC Salesheet.pdf

4•6•8.pdf